"Suzhou Zelgen Biopharmaceuticals Co., Ltd."Announcement on Voluntary Disclosure of Acceptance of the Supplemental New Drug Application for Human Thyrotropin Beta for Injection

Announcement on Voluntary Disclosure of Acceptance of the Supplemental New Drug Application for Human Thyrotropin Beta for Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment